Home › Multiple Myeloma › Connecticut › East Norwalk
Multiple Myeloma clinical trials in East Norwalk, CT
13 studies for Multiple Myeloma are looking for participants at sites in and around East Norwalk (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
RecruitingPhase 2
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack · 19 mi away
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
RecruitingPhase 3
- MSK Commack, Commack · 19 mi away
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
RecruitingPhase 2
- Memorial Sloan Kettering Suffolk-Commack (All Protocol Activity), Commack · 19 mi away
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
RecruitingPhase 3
- MSK Commack, Commack · 19 mi away
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
RecruitingPhase 1
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack · 19 mi away
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
RecruitingObservational study
- Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities), Commack · 19 mi away
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
RecruitingPhase 1/2
- Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities), Commack · 19 mi away
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
RecruitingPhase 2
- Memorial Sloan Kettering Cancer Center Suffolk - Commack (Limited Protocol Activities), Commack · 19 mi away
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
RecruitingPhase 2
- Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (All Protocol Activities), Commack · 19 mi away
A Dietary Study for People With Multiple Myeloma
Recruiting
- Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack · 19 mi away
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
RecruitingPhase 2
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack · 19 mi away
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RecruitingObservational studyHealthy volunteers welcome
- Memorial Sloan Kettering Commack, Commack · 19 mi away
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Recruiting
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack · 19 mi away
About Multiple Myeloma
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.
More about Multiple Myeloma on MedlinePlus
Multiple Myeloma trials in other cities
- New York City, NY60 studies
- Boston, MA42 studies
- Atlanta, GA41 studies
- Houston, TX38 studies
- Durham, NC37 studies
- Nashville, TN32 studies
- Denver, CO27 studies
- Rochester, MN24 studies
- St. Louis, MO24 studies
- Columbus, OH24 studies
- Baldwin Park, CA23 studies
- Chicago, IL22 studies
Other studies in East Norwalk
- Breast Cancer35 studies
- Non-Small Cell Lung Cancer18 studies
- Prostate Cancer16 studies
- Acute Myeloid Leukemia14 studies
- Endometrial Cancer12 studies
- Cancer (all types)10 studies
- Ovarian Cancer10 studies
- Bladder Cancer10 studies
- Lung Cancer10 studies
- Colorectal Cancer8 studies
- Metastatic Cancer8 studies
- Lymphoma8 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.